跳至主要内容
临床试验/CTRI/2025/03/082128
CTRI/2025/03/082128尚未招募不适用

Comparative evaluation of the Anesthetic efficacy of 4 Percent Articaine using 3 different supplemental injection techniques in Mandibular 1st Molar after failed Inferior Alveolar Nerve Block- A Randomised Clinical Trial

Sandhi Jaswal1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年4月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Pain assessment will be conducted following the administration of a supplemental anesthetic injection after a failed inferior alveolar nerve block, during access opening, initial file placement and instrument the tooth using a 10-point pain intensity scale post-treatment.

研究概览

简要总结

To assess the anesthetic efficacy of 4% articaine using supplemental Buccal Infiltration, Intraligamentary injection and Intrapulpal injection in mandibular 1st molar after failed Inferior Alveolar Nerve Block.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient experiencing spontaneous and moderate to severe pain in mandibular 1st Molar diagnosed with symptomatic irreversible pulpitis
  • Patients in the age group of 18-60 years
  • Mature teeth with closed apex 4.

排除标准

  • Patients with History of significant medical conditions
  • Patient allergic to local anesthesia or sulfides
  • Pregnant women
  • Patients having active sites of pathosis in the area of injection
  • No bleeding after access opening
  • Teeth with periapical radiolucency
  • Patients who consumed medications like analgesics, narcotics, sedation, antianxiety or antidepressants before the treatment
  • Patients having any other region of active pain in the same quadrant along with mandibular 1st molar.

结局指标

主要结局

Pain assessment will be conducted following the administration of a supplemental anesthetic injection after a failed inferior alveolar nerve block, during access opening, initial file placement and instrument the tooth using a 10-point pain intensity scale post-treatment.

时间窗: The Supplemental Injection will be given 15 minutes after the IANB.

次要结局

  • NA(NA)

研究者

发起方
Sandhi Jaswal
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Sandhi Jaswal

Bhojia Dental College and Hospital

研究点 (1)

Loading locations...

相似试验